The use of intravenous immunoglobulin in dengue shock syndrome a randomized double blind placebo controlled trial
To determine the efficacy of intravenous immunoglobulin (IVIG) in affecting the outcome of pediatric patients with Dengue Shock Syndrome (DSS). Randomized double-blind placebo controlled trial at De La Salle University Medical Center, Dasmari?as, Cavite.Two hundred five consecutive patients aged six...
| Autore principale: | |
|---|---|
| Natura: | Tesi |
| Lingua: | English |
| Soggetti: |